Form D · Other Technology
Gene Matters, LLC
Minneapolis, MN · CIK 0001709403
Offering snapshot reported Jul 22, 2020 · SEC filing
- Reported sold
- $10.2M Offering amount: $10.2M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 7, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 22, 2020 | Initial | $10,197,928 | No comparison | 8 | SEC filing |
| May 3, 2019 | Initial | $129,997 | No comparison | 2 | SEC filing |
| Jun 15, 2017 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-371546
Source: Form D, filed Jul 22, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brent Backhaus | Director |
| Danny Cunagin | Director |
| Jill Davies | Director, Executive |
| Troy Kopischke | Director |
| Mark Sylvester | Executive |
| Steve Troutner | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
807 Broadway Street Ne Suite 350
Minneapolis, MN, 55413
Minneapolis, MN, 55413